EGFR and head and neck squamous cell carcinoma: Although EGFR is not defined as an angiogenetic factor, it was investigated in HNSCC since it is active in various intracellular signal pathways, where it has been found involved in stimulating the angiogenesis in addition to cell proliferation, causing an inhibition of programmed cell death and a stimulation of progression in the cell cycle [113].